- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Interventional oncology turns profit for rad groups
Interventional oncology practices can provide radiology departments with generous revenue despite the costly investment required to provide image-guided therapies.
Interventional oncology practices can provide radiology departments with generous revenue despite the costly investment required to provide image-guided therapies.
Dr. Catherine Tuite and colleagues at the University of Pennsylvania reviewed data from 68 patients who underwent radiofrequency ablation of liver tumors at Penn's outpatient interventional radiology clinic from 1999 to 2003. They recorded all aspects involved with the management of interventional oncology patients, including initial consultation, diagnostic imaging, intervention, and follow-up.
The relative value units drawn against standard payment rates from the Centers for Medicare and Medicaid Services provided the department with total professional revenue of $7000 and $10,000 per each new ablation and chemoembolization patient, respectively. The average revenue to the radiology practice totaled more than $120,000 annually, coauthor Dr. Michael C. Soulen said at the meeting of the Society of Interventional Radiology in April.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
